Create issue ticket

9,617 Possible Causes for I, PACAP, RECEPTOR,, TYPE

Did you mean: I, pica, RECEPTOR, TYPE

  • Thyrotropin

    The RAIU were measured 24 and 48 hours after the rhTSH and then all the patients were administered therapeutic doses of I-131.[ncbi.nlm.nih.gov] , G-Protein-Coupled/chemistry Receptors, G-Protein-Coupled/classification Receptors, G-Protein-Coupled/genetics Receptors, Thyrotropin/chemistry* Receptors, Thyrotropin/genetics[ncbi.nlm.nih.gov] VIP / PACAP VIPR 1 Agonists: Peptide: Bay 55-9837 LBT-3393 PACAP VIP VIPR 2 Agonists: Peptide: LBT-3627 PACAP VIP PAC 1 Agonists: PACAP PACAP (1-27) PACAP (1-38) Antagonists[en.wikipedia.org] However, the effect of serum TSH might depend on histological types of thyroid cancer.[ncbi.nlm.nih.gov]

  • Insulin-Like Growth Factor I

    Recombinant human IGF-I (rhIGF-I) treatment is effective in promoting growth in subjects who have GHIS.[ncbi.nlm.nih.gov] […] little is known on whether this receptor can be targeted by neuropsychopharmacological agents.[ncbi.nlm.nih.gov] LIF) Macrophage-stimulating protein (MSP; HLP, HGFLP) Midkine (NEGF2) Migration-stimulating factor (MSF; PRG4) Oncomodulin Pituitary adenylate cyclase-activating peptide (PACAP[en.wikipedia.org] KEYWORDS: Growth hormone; Height; Insulin like growth factor-I; Portal hypoinsulinization; Type 1 diabetes[ncbi.nlm.nih.gov]

  • Glucagon

    I generally do not recommend the pinching technique; there is always a small risk the needle could accidentally prick your finger while you pinch the skin and deliver an injection[diabetesforecast.org] Binding analysis revealed that the total number of glucagon receptors on liposarcoma-cells was 99,000 and the apparent receptor affinity (ED:50) was 5 x 10(-9) M.[ncbi.nlm.nih.gov] Sherwood NM, Krueckl SL, McRory JE: The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily.[mayomedicallaboratories.com] BACKGROUND: The incretin effect is impaired in patients with type 2 diabetes.[ncbi.nlm.nih.gov]

  • Upper Respiratory Infection

    During the following year, 31 subjects reattended for challenge testing during URI (I) and after recovery (R).[ncbi.nlm.nih.gov] Rhinitis*/microbiology Substances Receptors, G-Protein-Coupled taste receptors, type 2 Grant support P30DC011735/DC/NIDCD NIH HHS/United States P30 DC011735/DC/NIDCD NIH[ncbi.nlm.nih.gov] In addition to the common cold, there are other types of URIs: Sinusitis Sinusitis is inflammation of the sinuses.[healthline.com] I am a privileged white man and an avowed centrist. As such, I want the Women’s March to succeed. I want to support a movement...[jewishjournal.com]

    Missing: PACAP
  • Carbachol

    TPA did not have any effect per se, but blunted the effect of PACAP-27 on both NPR-A density and NPR-A mRNA.[ncbi.nlm.nih.gov] After removal of Ca (o), both AII and carbachol elicited a second rise of [Ca ]i. Thapsigargin (1 microM) prevented these second rises of [Ca ]i.[ncbi.nlm.nih.gov] The molecular mechanisms involved in the regulation of muscarinic receptor gene expression are poorly understood.[ncbi.nlm.nih.gov] The authors studied the effect of the nonspecific cationic channel blocker La (100 microm), of the L-type Ca channel blocker nitrendipine (10 microm), and of the N-type Ca[ncbi.nlm.nih.gov]

  • Appendicitis

    Grades of perforation were: I, 20.5%; II, 37.7%; III, 10.7%; IV, 31.1%.[ncbi.nlm.nih.gov] BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) is a new biomarker of inflammation level.[ncbi.nlm.nih.gov] To prevent unnecessary appendectomy, this type of infection should be made to ask in the history and clinical findings of patients.[ncbi.nlm.nih.gov] TYPE OF STUDY: Retrospective Case-Control Study. LEVEL OF EVIDENCE: Level III. Published by Elsevier Inc.[ncbi.nlm.nih.gov]

    Missing: PACAP
  • Neuroblastoma

    All these data give new insight regarding PACAP/VIP regulatory role in NB progression. Copyright 2018 Elsevier Ltd. All rights reserved.[ncbi.nlm.nih.gov] Preoperative assessment by nuclear medicine techniques showed weak uptake of I-MIBG and F-FDOPA contrasting with high F-FDG uptake by the tumor.[ncbi.nlm.nih.gov] […] transfer is a new immune-therapeutic approach whose efficacy may be boosted by several anticancer agents able to induce the expression of ligands for NK cell-activating receptors[ncbi.nlm.nih.gov] Such type of tumors can be surgically removed.[symptoma.com]

  • Miliaria

    Abstract Type I pseudohypoaldosteronism, an autosomal recessive, life-threatening disorder of mineralocorticoid resistance leads to excessive loss of sodium chloride through[ncbi.nlm.nih.gov] In kidney, PHA1 may occur primarily by mutations in the subunits of the sodium channel or in the mineralocorticoid receptors, and secondarily by several renal disorders.[ncbi.nlm.nih.gov] Abstract Type I pseudohypoaldosteronism, an autosomal recessive, life-threatening disorder of mineralocorticoid resistance leads to excessive loss of sodium chloride through[ncbi.nlm.nih.gov] Department of Pediatrics, Ministry of Health Bakirkoy Maternity and Children Education Hospital, Istanbul, Turkey. [email protected] Abstract Pseudohypoaldosteronism type[ncbi.nlm.nih.gov]

    Missing: PACAP
  • Mitoxantrone

    Additionally, mitoxantrone was found to bind i-motif forming sequences preferentially over double helical DNA.[ncbi.nlm.nih.gov] Background: A previous study developed a novel luteinizing hormone-releasing hormone (LHRH) receptor-targeted liposome.[ncbi.nlm.nih.gov] We tested the hypothesis that PACAP can protect against MXT-induced cardiotoxicity in mice.[ncbi.nlm.nih.gov] Datasheet References Product name Mitoxantrone dihydrochloride, Type II topoisomerase inhibitor Description Type II topoisomerase inhibitor Biological description Type II[abcam.com]

  • Sudden Infant Death Syndrome

    SIDS compared to non-SIDS had higher PACAP in the MBDR (p Copyright 2017 Elsevier Inc. All rights reserved.[ncbi.nlm.nih.gov] , Edificio Multiusos I D i, C/Espejo SN, 37007 Salamanca, Spain. [email protected] 3 BISITE Digital Innovation Hub., University of Salamanca, Edificio Multiusos I D i, C/Espejo[ncbi.nlm.nih.gov] METHODS: We have evaluated the expression and distribution of the orexin receptors (orexin-1 and orexin-2 receptors) particularly in the rostral pons, where the KFN is located[ncbi.nlm.nih.gov] The CNS changes were of hypoxic type and might have been caused at delivery or shortly after delivery.[ncbi.nlm.nih.gov]